- 6.23.2026
- Press Releases
VETS Ibogaine Grant Recipients Participate in New Research on Magnesium-Ibogaine and Blast TBI
New iScience publication builds on the same Stanford Brain Stimulation Lab dataset first reported in Nature Medicine and reflects VETS’ commitment to access, research, and responsible systems change
- 6.11.2026
- Press Releases
VETS Leads Push in Massachusetts and North Carolina for Psychedelic-Assisted Therapy Legislation
VETS will host Legislative Days of Action in North Carolina and Massachusetts this June, bringing veterans, researchers, and advocates together to educate lawmakers and advance state legislation supporting research and regulated access pathways for psychedelic-assisted therapies to address the veteran mental health crisis.
- 3.10.2026
- Press Releases
VETS Co-Founder & CEO Amber Capone Named to Inc.'s 2026 Female Founders 500 List for Second Consecutive Year
Amber Capone, co-founder and CEO of VETS, has been named to Inc.’s 2026 Female Founders 500 List for the second consecutive year, recognizing her leadership in advancing research, policy reform, and expanded access to psychedelic-assisted therapies for veterans.